Affymetrix introduces GeneAtlas System for processing arrays and characterizing changes in gene expression

NewsGuard 100/100 Score

Affymetrix, Inc. (NASDAQ: AFFX) today announced the launch of the GeneAtlas™ System, a complete, personal solution for processing Affymetrix arrays and characterizing changes in gene expression in a variety of research applications.

“We see opportunities to develop the microarray gene expression market by making it more accessible to new users”

By combining Affymetrix’ market-leading gene expression technology with the simplest workflow available and an unprecedented price, the GeneAtlas System extends the power of whole-genome microarray analysis to researchers who are constrained by budget or intimidated by the complexity of microarray systems.

"The GeneAtlas System gives life science researchers like me an independence we did not have before,” said Steve White, PhD, technical director of the Professional Science Master of Biotechnology Program at San Jose State University and one of the first scientists to use the GeneAtlas System. “It took us less than two hours to install and required no tools or engineers to help. That speed and ease of use continues with experiments, which can be initiated in less than five minutes. On top of that, the size of the system enables my scientists to do their work even in our small lab."

The system, which is available immediately, includes all required instrumentation, training materials, and easy-to-use data analysis programs that provide biologically relevant results. It’s designed to meet the needs of researchers with no microarray experience, as well as low- to medium-throughput service laboratories, educational laboratories, and emerging markets.

“We see opportunities to develop the microarray gene expression market by making it more accessible to new users,” said Greg Fisher, associate director of product marketing, systems and software, at Affymetrix. “We have bundled everything a researcher needs in one complete, affordable system.”

The GeneAtlas System utilizes a convenient new array strip format that enables researchers to interrogate four distinct samples simultaneously. Array strips are now available in options that provide comprehensive coverage of the transcribed human, mouse, or rat genomes for expression profiling. The array strip is also available for custom array designs through the MyGeneChip™ Custom Array Program. Additional arrays and applications will be introduced in the future.

“The GeneAtlas System eliminates workflow, data analysis, and cost barriers to performing whole-genome analysis,” said Kevin King, president and CEO of Affymetrix. “Affymetrix is providing a new generation of life science researchers with a system that offers uncompromised performance.”


Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ANU scientists uncover gene mutation driving psoriasis and psoriatic arthritis